Table 2.
Reviewed variables classified depending on its association with stroke outcome
| Stroke outcome (acute and sub-acute) | Baseline variable | Early outcome variable | Genetic factor |
|---|---|---|---|
| Associated | Glucose levels or diabetes mellitus | Stroke severity | rs20417 (located in COX-2 gene) |
| Blood pressure | Type of acute treatment performed | ||
| Atrial fibrillation | Sever neurological complications (PH-2) | ||
| Prior statin treatment | Leukocyte levels | ||
| Might associated | Hyperlipidemia | Leukoaraiosis | Candidate genes: |
| Renal dysfunction | Stroke etiology | CYP | |
| Prior infections | PTGIS | ||
| Blood platelet counts | TBXAS1 | ||
| Red blood cells or hemoglobin levels | P2RY1 | ||
| ITGB3 | |||
| Unknown | Heart failure | Cerebral edema | |
| Prior dementia | Gastrointestinal bleeding | ||
| Prior disability | Dysphagia | ||
| No associated | Age | ||
| Sex | |||
| Ethnicity | |||
| Body mass index |
PH-2, parenchymal hematoma 2; COX-2, cyclooxygenase-2; CYP, cytochrome P450; PTGIS, prostaglandin I2 synthase; TBXAS1, thromboxane A synthase 1; P2RY1, purinergic receptor P2Y1; ITGB3, integrin subunit beta 3.